Although the use of aprotinin has been well documented for cardiac surgical procedures, its use in lung transplantation has received less attention. Herein is the experience at Washington University with aprotinin in patients undergoing lung transplantation (most with cystic fibrosis). In these patients, bleeding from the chest wall is a major problem due to the dense adhesions from chronic infection. Aprotinin has a dramatic effect in reducing bleeding.
Get full access to this article
View all access options for this article.
References
1.
Egan TM, Duffin J., Glynn Mfx et al. Ten year experience with extracorporeal membrane oxygenation for severe respiratory failure. Chest1988 ; 94: 681-7.
2.
Pasque MK, Cooper JD, Kaiser LR, Haydock DA, Triantafillou A., Trulock EPImproved technique for bilateral lung transplantation: rationale and initial clinical experience. Ann Thorac Surg1990; 49: 785-91.
